Non-cystic fibrosis bronchiectasis.
暂无分享,去创建一个
[1] Megan L. Martin,et al. Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. , 2011, Respiratory medicine.
[2] B. Karadag,et al. Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries. , 2011, Paediatric respiratory reviews.
[3] L. Bahadorzadeh,et al. Surgical Management of Bronchiectasis: Analysis of 277 Patients , 2010, The Thoracic and cardiovascular surgeon.
[4] A. Hill,et al. Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis , 2009, European Respiratory Journal.
[5] A. Hill,et al. Assessing response to treatment of exacerbations of bronchiectasis in adults , 2008, European Respiratory Journal.
[6] A. Hasani,et al. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis , 2008, Chronic respiratory disease.
[7] S. Anderson,et al. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis , 2008, European Respiratory Journal.
[8] N. Müller,et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. , 2008, American journal of respiratory and critical care medicine.
[9] J. Soriano,et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. , 2007, Chest.
[10] P. King,et al. Microbiologic follow-up study in adult bronchiectasis. , 2007, Respiratory medicine.
[11] R. Wilson,et al. Aetiology in adult patients with bronchiectasis. , 2007, Respiratory medicine.
[12] J. Bradley,et al. Acapella ® versus `usual airway clearance' during acute exacerbation in bronchiectasis: a randomized crossover trial , 2007, Chronic respiratory disease.
[13] I. Zeng,et al. A randomized evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis , 2007, Chronic respiratory disease.
[14] P. King,et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. , 2006, Respiratory medicine.
[15] S. Fowler,et al. Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics , 2006, European Respiratory Journal.
[16] G. Fischer,et al. Non-cystic-fibrosis bronchiectasis: a perspective from South America. , 2006, Paediatric respiratory reviews.
[17] R. Wilson,et al. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis , 2006, European Respiratory Journal.
[18] M. Martínez-García,et al. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. , 2006, Respiratory medicine.
[19] R. Wilson,et al. Non-tuberculous mycobacteria in patients with bronchiectasis , 2005, Thorax.
[20] M. Martínez-García,et al. Quality-of-life determinants in patients with clinically stable bronchiectasis. , 2005, Chest.
[21] G. Oster,et al. Prevalence and Economic Burden of Bronchiectasis , 2005 .
[22] C. Byrnes,et al. New Zealand national incidence of bronchiectasis “too high” for a developed country , 2005, Archives of Disease in Childhood.
[23] I. Bradbury,et al. Airway Clearance in Bronchiectasis: A Randomized Crossover Trial of Active Cycle of Breathing Techniques versus Acapella® , 2005, Respiration.
[24] M. Chan-yeung,et al. Inhaled fluticasone in bronchiectasis: a 12 month study , 2005, Thorax.
[25] P. Suñé,et al. Inhaled Tobramycin in Non—Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection with Pseudomonas Aeruginosa , 2005, The Annals of pharmacotherapy.
[26] S. Anderson,et al. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum , 2005, Respirology.
[27] J. Wedzicha,et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[28] B. Morrissey,et al. Bronchiectasis: sex and gender considerations. , 2004, Clinics in chest medicine.
[29] J. Elborn,et al. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. , 2003, European journal of internal medicine.
[30] A. Gözübüyük,et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[31] P. Cole,et al. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum , 2003, Respirology.
[32] D. Smith,et al. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis , 2002, Thorax.
[33] R. Rodríguez-Roisín,et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors , 2002, Thorax.
[34] J. Bradley,et al. THE CURRENT PHYSIOTHERAPY MANAGEMENT OF PATIENTS WITH BRONCHIECTASIS: A UK SURVEY , 2002, International journal of clinical practice.
[35] C. Agustí,et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. , 2001, American journal of respiratory and critical care medicine.
[36] S. Anderson,et al. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. , 2001, Chest.
[37] M. Keogan,et al. An investigation into causative factors in patients with bronchiectasis. , 2000, American journal of respiratory and critical care medicine.
[38] R. Stockley,et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.
[39] P. Ho,et al. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. , 1999, The European respiratory journal.
[40] G. Sampol,et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. , 1999, Respiratory medicine.
[41] S. Anderson,et al. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. , 1999, American journal of respiratory and critical care medicine.
[42] Wai Lam,et al. A pilot study of low-dose erythromycin in bronchiectasis. , 1999, The European respiratory journal.
[43] K. Yuen,et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. , 1998, American journal of respiratory and critical care medicine.
[44] S. Durham,et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis , 1998, Thorax.
[45] A. O'donnell,et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. , 1998, Chest.
[46] P. Jones,et al. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. , 1997, American journal of respiratory and critical care medicine.
[47] D. Symmons,et al. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. , 1997, British journal of rheumatology.
[48] M. Nicotra,et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. , 1995, Chest.
[49] J. Bernaudin,et al. Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. , 1995, American journal of respiratory and critical care medicine.
[50] J. Elborn,et al. Inhaled steroids in patients with bronchiectasis. , 1992, Respiratory medicine.
[51] J. Fleming,et al. Humidification as an adjunct to chest physiotherapy in aiding tracheo-bronchial clearance in patients with bronchiectasis. , 1992, Respiratory medicine.
[52] H. Todd,et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. , 1990, The Quarterly journal of medicine.
[53] R. Stockley,et al. Effect of short and long term antibiotic response on lung function in bronchiectasis. , 1986, Thorax.
[54] S. Siegelman,et al. Computed Tomography of Bronchiectasis , 1982, Journal of computer assisted tomography.
[55] H. Raafat,et al. Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis. Controlled trials of increasing dosage of cephaloridine. , 1967, British journal of diseases of the chest.
[56] G. Jackson,et al. ADVERSE REACTIONS TO TETRACYCLINE, PENICILLIN AND AN OLEANDOMYCIN-PENICILLIN MIXTURE USED IN THE LONG-TERM THERAPY OF CHRONIC PULMONARY DISEASE , 1962, The American journal of the medical sciences.
[57] J. Maurer. Trends and Burden of Bronchiectasis-Associated Hospitalizations in the United States, 1993-2006 , 2011 .
[58] M. Raza. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis , 2010 .
[59] A. Arroliga,et al. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis , 2010 .
[60] N. Uzuner,et al. A neglected problem of developing countries: Noncystic fibrosis bronchiectasis , 2009, Annals of thoracic medicine.
[61] Christina C. Chang,et al. Pneumococcal vaccines for children and adults with bronchiectasis. , 2007, The Cochrane database of systematic reviews.
[62] J. May,et al. The Disease-Modifying Effects of Twice-Weekly Oral Azithromycin in Patients with Bronchiectasis , 2005, Treatments in respiratory medicine.
[63] R. Niven,et al. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. , 2005, Respiratory medicine.
[64] R. Wilson,et al. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. , 2004, Thorax.
[65] A. Sheikh,et al. Short acting beta-2 agonists for bronchiectasis. , 2003, The Cochrane database of systematic reviews.
[66] A. Sheikh,et al. Long-acting beta-2-agonists for bronchiectasis. , 2001, The Cochrane database of systematic reviews.
[67] A. Crockett,et al. Mucolytics for bronchiectasis. , 2001, The Cochrane database of systematic reviews.
[68] Kenneth Meyer,et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. , 2000, American journal of respiratory and critical care medicine.
[69] S. Simon,et al. Aerosolized antibiotics in mechanically ventilated patients: delivery and response. , 1998, Critical care medicine.
[70] P. Cole. Inflammation: a two-edged sword--the model of bronchiectasis. , 1986, European journal of respiratory diseases. Supplement.
[71] J. V. van Noord,et al. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime. , 1983, The Journal of antimicrobial chemotherapy.
[72] PROLONGED antibiotic treatment of severe bronchiectasis; a report by a subcommittee of the Antibiotics Clinical Trials (non-tuberculous) Committee of the Medical Research Council. , 1957, British medical journal.
[73] W. Warner. BRONCHIECTASIS: AETIOLOGY, DIAGNOSIS AND TREATMENT. , 2022, Canadian Medical Association journal.